Source: Annual Congress 2008 - Understanding airway inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Provoost, Y. van Durme, G. F. Joos, T. Maes, K. G. Tournoy (Ghent, Belgium). Reduced numbers of circulating CD4⁺CD25^highFOXP3⁺ regulatory T cells in patients with allergic asthma. Eur Respir J 2008; 32: Suppl. 52, 4453

Member's Comments

No comment yet.

Related content which might interest you: T regulatory cells decrease before asthma exacerbations Source: Annual Congress 2008 - Understanding the mechanisms and the impact of severe asthma Year: 2008 Low number of regulatory T cells in bronchial asthma: association with inflammatory cytokines Source: Annual Congress 2009 - Infections, immunity and inflammation Year: 2009 Increased levels of CD4+CD25high and CD4+FoxP3+ T-regulatory cells (Tregs) in patients with different severity of bronchial asthma (BA) Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD Year: 2011 Expression of surface markers on peripheral CD4+CD25high T cells in patients with atopic asthma: role of inhaled corticosteroid Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008 Effects of depletion of CD4+CD25+ T cells with anti-CD25McAb on airway inflammation of asthmatic mice Source: Eur Respir J 2005; 26: Suppl. 49, 24s Year: 2005 Activin-A induces human regulatory T cells that control allergic asthma Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 T-regulatory cells blood content in patients with asthma exacerbation Source: Annual Congress 2011 - T-cell subsets Year: 2011 Increase of both blood CXCR3+ and CCR4+ helper T cells associated with severity of asthma Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma Year: 2005 Omalizumab enhances the percentage of GARP cells in both regulatory and terminally differentiated effector Th cells in severe allergic asthmatics Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018 Reduced bronchial CD4+ T cell activation in smokers with occupational asthma Source: Eur Respir J 2006; 28: Suppl. 50, 592s Year: 2006 The role of regulatory T cells in differentiating asthma from COPD Source: Eur Respir J 2007; 30: Suppl. 51, 373s Year: 2007 Different profiles of lung and systemic regulatory T cells in mild asthmatics Source: Annual Congress 2010 - COPD and asthma: models and human studies Year: 2010 Enhanced expression of IL-18 and increased CD8+ T cells and eosinophils in the airways of asthma death Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010 CD39/CD73 and the imbalance of Th17 and Tregs (regulatory T cells) in allergic asthma Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Diminished levels of IL-7 receptor-positive CD4+ T cells in asthmatic patients are up-regulated by glucocorticoid therapy. No effects on IL-7R-negative regulatory CD4+ T cells Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010 Comparative characteristics of regulatory T cells populations between patients with bronchial asthma (BA) and COPD Source: Annual Congress 2011 - T-cell subsets Year: 2011 The declined CD4+ CD25+Treg cells in patients with moderate to severe asthma associated with over-expressed Th2 response Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 IL-10-producing CD4+ T cells are essential for the development of airway hyperresponsiveness Source: Annual Congress 2004 - Modulation of the allergic response in animal models Year: 2004 Regulatory T cells and L-selectin in severe asthmatic patients treated with mepolizumab. Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020 Upregulation of CD4+ and CD8+ cells expressing CX3CR1 in asthmatics Source: Annual Congress 2006 - Towards understanding the pathogenesis of asthma Year: 2006